December 13, 2013
Kyowa Hakko Kirin and Hisamitsu Pharmaceutical launched the cancer pain treatment Abstral Sublingual Tablets 100 μg, 200 μg, and 400 μg (fentanyl citrate) on December 12. The two companies have concluded a comarketing agreement and will market the product through...read more